Dilated cardiomyopathy is conventionally defined as the presence of left ventricular or
biventricular dilatation or systolic dysfunction in the absence of abnormal loading conditions …

Recent years have witnessed significant transformations in cardiovascular medicine, driven
by the rapid evolution of artificial intelligence (AI). This scoping review was conducted to …

Dilated cardiomyopathy (DCM) is a leading cause of heart failure and cardiac
transplantation. We report a genome-wide association study and multi-trait analysis of DCM …

Abstract Purpose of Review The introduction of Artificial Intelligence into the healthcare
system offers enormous opportunities for biomedical research, the improvement of patient …

Artificial intelligence (AI) is rapidly being applied to the medical field, especially in the
cardiovascular domain. AI approaches have demonstrated their applicability in the …

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an important cause of sudden
cardiac death associated with heterogeneous phenotypes, but there is no systematic …

Dilated cardiomyopathy (DCM) is a complex disease with multiple causes and various
pathogenic mechanisms. Despite improvements in the prognosis of patients with DCM in the …

Our understanding of dilated cardiomyopathy (DCM) is evolving as new insights into the
underlying pathophysiology become available. Professional organizations and clinical …

BACKGROUND: There is growing evidence that pathogenic mutations do not fully explain
hypertrophic (HCM) or dilated (DCM) cardiomyopathy phenotypes. We hypothesized that if a …

Dilated cardiomyopathy represents a common phenotype expressed in individuals with a
family of overlapping myocardial diseases due to acquired and/or genetic susceptibility …